ALLR
Allarity Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
−0.70%Margins
Gross margin
107.5%
EBITDA margin
-3213.0%
EBIT margin
-3129.0%
Net margin
-3575.1%
FCF margin
-3994.8%
-348.8%
Return on equity
-38.4%
Return on assets
-41.8%
Return on invested capital
0.01x
Asset turnover
-$13.7M
Cash from operations
$1.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026